Wait a quarter or so, then consider buying pharma stocks: Rahul Shah
“Coming back to the new age tech story, it is a pretty long play. Near term, the challenges will remain. If we are looking at one or two quarters, then things look a little difficult. But if you look at a three-four year story, then it is a unique listed player, one we can look at and if we have a deep pockets, allocate it. We should look at Zomato for a four-five year play from here.”